Smoking Cessation: Discontinuation of the habit of smoking, the inhaling and exhaling of tobacco smoke.Tobacco Use Cessation: Ending the TOBACCO habits of smoking, chewing, or snuff use.Tobacco Use Cessation Products: Items used to aid in ending a TOBACCO habit.Smoking: Inhaling and exhaling the smoke of burning TOBACCO.Bupropion: A unicyclic, aminoketone antidepressant. The mechanism of its therapeutic actions is not well understood, but it does appear to block dopamine uptake. The hydrochloride is available as an aid to smoking cessation treatment.Tobacco Use Disorder: Tobacco used to the detriment of a person's health or social functioning. Tobacco dependence is included.Nicotine: Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke.Nicotinic Agonists: Drugs that bind to and activate nicotinic cholinergic receptors (RECEPTORS, NICOTINIC). Nicotinic agonists act at postganglionic nicotinic receptors, at neuroeffector junctions in the peripheral nervous system, and at nicotinic receptors in the central nervous system. Agents that function as neuromuscular depolarizing blocking agents are included here because they activate nicotinic receptors, although they are used clinically to block nicotinic transmission.Hotlines: A direct communication system, usually telephone, established for instant contact. It is designed to provide special information and assistance through trained personnel and is used for counseling, referrals, and emergencies such as poisonings and threatened suicides.Motivation: Those factors which cause an organism to behave or act in either a goal-seeking or satisfying manner. They may be influenced by physiological drives or by external stimuli.Chewing Gum: A preparation of chicle, sometimes mixed with other plastic substances, sweetened and flavored. It is masticated usually for pleasure as a candy substitute but it sometimes acts as a vehicle for the administration of medication.Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.Benzazepines: Compounds with BENZENE fused to AZEPINES.Directive Counseling: Counseling during which a professional plays an active role in a client's or patient's decision making by offering advice, guidance, and/or recommendations.Administration, Cutaneous: The application of suitable drug dosage forms to the skin for either local or systemic effects.QuinoxalinesTreatment Outcome: Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.Time Factors: Elements of limited time intervals, contributing to particular results or situations.Health Promotion: Encouraging consumer behaviors most likely to optimize health potentials (physical and psychosocial) through health information, preventive programs, and access to medical care.Follow-Up Studies: Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.Tobacco, Smokeless: Powdered or cut pieces of leaves of NICOTIANA TABACUM which are inhaled through the nose, chewed, or stored in cheek pouches. It includes any product of tobacco that is not smoked.Cotinine: The N-glucuronide conjugate of cotinine is a major urinary metabolite of NICOTINE. It thus serves as a biomarker of exposure to tobacco SMOKING. It has CNS stimulating properties.Behavior Therapy: The application of modern theories of learning and conditioning in the treatment of behavior disorders.Questionnaires: Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument.Program Evaluation: Studies designed to assess the efficacy of programs. They may include the evaluation of cost-effectiveness, the extent to which objectives are met, or impact.United StatesPatient Education as Topic: The teaching or training of patients concerning their own health needs.Therapy, Computer-Assisted: Computer systems utilized as adjuncts in the treatment of disease.Dentists: Individuals licensed to practice DENTISTRY.Self Efficacy: Cognitive mechanism based on expectations or beliefs about one's ability to perform actions necessary to produce a given effect. It is also a theoretical component of behavior change in various therapeutic treatments. (APA, Thesaurus of Psychological Index Terms, 1994)Recurrence: The return of a sign, symptom, or disease after a remission.Dopamine Uptake Inhibitors: Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake.Antidepressive Agents, Second-Generation: A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake.Telephone: An instrument for reproducing sounds especially articulate speech at a distance. (Webster, 3rd ed)Risk Factors: An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.Attitude to Health: Public attitudes toward health, disease, and the medical care system.Intention: What a person has in mind to do or bring about.Prevalence: The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.Smoke-Free Policy: Prohibition against tobacco smoking in specific areas to control TOBACCO SMOKE POLLUTION.Self-Help Groups: Organizations which provide an environment encouraging social interactions through group activities or individual relationships especially for the purpose of rehabilitating or supporting patients, individuals with common health problems, or the elderly. They include therapeutic social clubs.Withholding Treatment: Withholding or withdrawal of a particular treatment or treatments, often (but not necessarily) life-prolonging treatment, from a patient or from a research subject as part of a research protocol. The concept is differentiated from REFUSAL TO TREAT, where the emphasis is on the health professional's or health facility's refusal to treat a patient or group of patients when the patient or the patient's representative requests treatment. Withholding of life-prolonging treatment is usually indexed only with EUTHANASIA, PASSIVE, unless the distinction between withholding and withdrawing treatment, or the issue of withholding palliative rather than curative treatment, is discussed.Health Behavior: Behaviors expressed by individuals to protect, maintain or promote their health status. For example, proper diet, and appropriate exercise are activities perceived to influence health status. Life style is closely associated with health behavior and factors influencing life style are socioeconomic, educational, and cultural.Ganglionic Stimulants: Agents that mimic neural transmission by stimulation of the nicotinic receptors on postganglionic autonomic neurons. Drugs that indirectly augment ganglionic transmission by increasing the release or slowing the breakdown of acetylcholine or by non-nicotinic effects on postganglionic neurons are not included here nor are the nonspecific cholinergic agonists.Pilot Projects: Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work.Nortriptyline: A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions.Internet: A loose confederation of computer communication networks around the world. The networks that make up the Internet are connected through several backbone networks. The Internet grew out of the US Government ARPAnet project and was designed to facilitate information exchange.Health Knowledge, Attitudes, Practice: Knowledge, attitudes, and associated behaviors which pertain to health-related topics such as PATHOLOGIC PROCESSES or diseases, their prevention, and treatment. This term refers to non-health workers and health workers (HEALTH PERSONNEL).Dental Hygienists: Persons trained in an accredited school or dental college and licensed by the state in which they reside to provide dental prophylaxis under the direction of a licensed dentist.Tobacco Products: Substances and products derived from NICOTIANA TABACUM.Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.Intervention Studies: Epidemiologic investigations designed to test a hypothesized cause-effect relation by modifying the supposed causal factor(s) in the study population.Prospective Studies: Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.Dental Offices: The room or rooms in which the dentist and dental staff provide care. Offices include all rooms in the dentist's office suite.Workplace: Place or physical location of work or employment.Social Support: Support systems that provide assistance and encouragement to individuals with physical or emotional disabilities in order that they may better cope. Informal social support is usually provided by friends, relatives, or peers, while formal assistance is provided by churches, groups, etc.Logistic Models: Statistical models which describe the relationship between a qualitative dependent variable (that is, one which can take only certain discrete values, such as the presence or absence of a disease) and an independent variable. A common application is in epidemiology for estimating an individual's risk (probability of a disease) as a function of a given risk factor.Health Education: Education that increases the awareness and favorably influences the attitudes and knowledge relating to the improvement of health on a personal or community basis.Cross-Sectional Studies: Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time.Patient Compliance: Voluntary cooperation of the patient in following a prescribed regimen.Advertising as Topic: The act or practice of calling public attention to a product, service, need, etc., especially by paid announcements in newspapers, magazines, on radio, or on television. (Random House Unabridged Dictionary, 2d ed)Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)Risk Reduction Behavior: Reduction of high-risk choices and adoption of low-risk quantity and frequency alternatives.Tobacco Smoke Pollution: Contamination of the air by tobacco smoke.Pregnant Women: Human females who are pregnant, as cultural, psychological, or sociological entities.Prenatal Care: Care provided the pregnant woman in order to prevent complications, and decrease the incidence of maternal and prenatal mortality.Neurolinguistic Programming: A set of models of how communication impacts and is impacted by subjective experience. Techniques are generated from these models by sequencing of various aspects of the models in order to change someone's internal representations. Neurolinguistic programming is concerned with the patterns or programming created by the interactions among the brain, language, and the body, that produce both effective and ineffective behavior.Double-Blind Method: A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.Telefacsimile: A telecommunication system combining the transmission of a document scanned at a transmitter, its reconstruction at a receiving station, and its duplication there by a copier.Socioeconomic Factors: Social and economic factors that characterize the individual or group within the social structure.Cost-Benefit Analysis: A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results.Taxes: Governmental levies on property, inheritance, gifts, etc.Transdermal Patch: A medicated adhesive patch placed on the skin to deliver a specific dose of medication into the bloodstream.Behavior, Addictive: The observable, measurable, and often pathological activity of an organism that portrays its inability to overcome a habit resulting in an insatiable craving for a substance or for performing certain acts. The addictive behavior includes the emotional and physical overdependence on the object of habit in increasing amount or frequency.Manuals as Topic: Books designed to give factual information or instructions.Longitudinal Studies: Studies in which variables relating to an individual or group of individuals are assessed over a period of time.Weight Gain: Increase in BODY WEIGHT over existing weight.Electronic Mail: Messages between computer users via COMPUTER COMMUNICATION NETWORKS. This feature duplicates most of the features of paper mail, such as forwarding, multiple copies, and attachments of images and other file types, but with a speed advantage. The term also refers to an individual message sent in this way.Interviews as Topic: Conversations with an individual or individuals held in order to obtain information about their background and other personal biographical data, their attitudes and opinions, etc. It includes school admission or job interviews.Health Surveys: A systematic collection of factual data pertaining to health and disease in a human population within a given geographic area.United States Public Health Service: A constituent organization of the DEPARTMENT OF HEALTH AND HUMAN SERVICES concerned with protecting and improving the health of the nation.Cohort Studies: Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.Physician's Role: The expected function of a member of the medical profession.Social Marketing: Use of marketing principles also used to sell products to consumers to promote ideas, attitudes and behaviors. Design and use of programs seeking to increase the acceptance of a social idea or practice by target groups, not for the benefit of the marketer, but to benefit the target audience and the general society.Dental Clinics: Facilities where dental care is provided to patients.Randomized Controlled Trials as Topic: Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.Attitude of Health Personnel: Attitudes of personnel toward their patients, other professionals, toward the medical care system, etc.Sex Factors: Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances.Organizational Policy: A course or method of action selected, usually by an organization, institution, university, society, etc., from among alternatives to guide and determine present and future decisions and positions on matters of public interest or social concern. It does not include internal policy relating to organization and administration within the corporate body, for which ORGANIZATION AND ADMINISTRATION is available.Mass Media: Instruments or technological means of communication that reach large numbers of people with a common message: press, radio, television, etc.Data Collection: Systematic gathering of data for a particular purpose from various sources, including questionnaires, interviews, observation, existing records, and electronic devices. The process is usually preliminary to statistical analysis of the data.Text Messaging: Communication between CELL PHONE users via the Short Message Service protocol which allows the interchange of short written messages.Age Factors: Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.Research Design: A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly.

*  Acclaimed Smoking-Cessation Program Now Available to Outpatients

Helena Center for Health's Smoke-Free Life® program ... A stop-smoking program costs much less than treating the health ... The Smoke-Free Life® team provides a medically monitored, personalized treatment approach that uses the latest smoking- ... smoking-cessation nurse specialist. 'We're bringing our acclaimed program to a broader audience for those who cannot take time ... Creation of the outpatient Smoke-Free Life® program is supported by a gift of $500,000 from the family of Marjorie Mondavi in ...

*  Nicotine Replacement for Smoking Cessation During Pregnancy - Full Text View -

This project will examine the safety and efficacy of the nicotine inhaler as an aid to smoking cessation during pregnancy. The ... Nicotine Replacement for Smoking Cessation During Pregnancy. This study has been completed. ... To examine the efficacy of the nicotine inhaler compared to a matched placebo for smoking cessation and reduction among ... To identify factors that determine which women benefit most from the use of nicotine inhaler for smoking cessation during ...

*  Smoking cessation in the dental setting: a practical approach.

Various smoking cessation methods that are available to dentists include nicotine replacement therapies, other pharmacological ... Smoking is a prevalent behavior with severe health consequences. ... Effects of rapid smoking on post-cessation urges to smoke.. ... Smoking is a prevalent behavior with severe health consequences. Various smoking cessation methods that are available to ... This article presents a smoking cessation protocol that can be carried out as part of routine oral care.. ...

*  Evaluation of Cardiovascular Effects of Smoking Cessation in HIV Patients - Full Text View -

Evaluation of Cardiovascular Effects of Smoking Cessation in HIV Patients. This study has been completed. ... The central hypothesis is that smoking cessation win slow the atherosclerosis progression in HIV patients. A successful ... HIV positive smokers who enroll in a smoking cessation trial who elect to participate in this substudy ... We will also evaluate rates of progression of CIMT in those who quit smoking versus those who continue smoking, based on race, ...

*  Smoking Cessation Drugs: Bupropion | Doctors Hospital

Learn more about Smoking Cessation Drugs: Bupropion at Doctors Hospital of Augusta Type of Medication Bupropion is an ... Smoking Cessation Success. It is very clear from all of the studies on smoking cessation that your chance of long-term success ... For example, you should not take bupropion for smoking cessation if you:. *Are already taking another drug that also contains ... Most people do not have side effects from taking bupropion for smoking cessation. If side effects do occur, they can usually be ...

*  Budgetary impact analysis on funding smoking-cessation drugs in patien | COPD

Funding smoking-cessation drugs in COPD patients seems to be an efficient option and a National Health System drug ... The pharmaceutical costs for smoking-cessation drugs, extra medical follow-up as a consequence of public reimbursement, and ... Keywords: pharmacotherapy, COPD, smoking cessation, budgetary impact, health service ... The aim of the study was to assess the budgetary impact of funding smoking-cessation drugs in COPD patients in Spain. A hybrid ...

*  The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia - Full...

3. Smoke cessation is associated with a significant decrease in the activity of CYP1A2, as well as a significant increase in ... An important related issue is the influence of smoking, and its cessation, on the effects of the medications most of these ... It is unclear to what extent smoke cessation (as well as initiation) changes the side effect profiles of these medications, and ... 4) to examine the predictive value of the stages of change on smoking cessation and reduction outcomes in schizophrenic ... Clinical Trials&rank=19

*  Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who...

A smoking cessation (stop-smoking) program that combines contingency management with bupropion and counseling may be effective ... Patients are randomized to 1 of 2 smoking cessation intervention arms.. *Arm I: Patients receive oral bupropion twice daily on ... Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who ... Compare the feasibility of a multi-component smoking cessation intervention comprising bupropion and counseling with or without ...

*  A Pilot Study Of Smoking Cessation Treatment Including Varenicline In Patients Scheduled For Planned Surgery - Full Text View -...

A Pilot Study Of Smoking Cessation Treatment Including Varenicline In Patients Scheduled For Planned Surgery. This study has ... Smoking cessation tratment including varenicline Drug: Varenicline Varenicline film coated tablets - escalating dose with ... A Multicenter, Open Label Study To Investigate The Feasibility And Efficacy Of A Smoking Cessation Program With Varenicline In ... It is possible to offer smoking cessation treatment including varenicline to patients scheduled for elective surgery. This ...

*  D-cycloserine (DCS) Pretreatment + Cognitive Behavioral Therapy and Nicotine Replacement Therapy for Smoking Cessation (DCS) -...

... current NRT or other smoking cessation treatment;9) current CBT for smoking cessation; 10) current smokeless tobacco use; 11) ... Nicotine Dependence Smoking Cessation Behavioral: Cognitive Behavioral Therapy Drug: Nicotine Replacement Therapy Phase 1 Phase ... D-cycloserine (DCS) Pretreatment + Cognitive Behavioral Therapy and Nicotine Replacement Therapy for Smoking Cessation (DCS) ( ... D-cycloserine (DCS) Pretreatment + Cognitive Behavioral Therapy and Nicotine Replacement Therapy for Smoking Cessation. ..."Smoking Cessation"&rank=16

*  Poly-Tobacco Use Among HIV-Positive Smokers: Implications for Smoking Cessation Efforts

Introduction: Poly-tobacco use is defined as cigarette and other tobacco consumption with either product used daily or nondaily. While concurrent use of different types of tobacco has been documented within the general population, less is known about poly-tobacco use among HIV-positive smokers and its impact on smoking cessation efforts. Objective: To characterize the profile of poly-tobacco users (PTU) in a sample of HIV-positive smokers participating in a cessation program. Methods: The study sample consisted of 474 HIV-positive smokers enrolled in a 2-group randomized controlled trial of cigarette smoking cessation comparing a cell phoneâ€"based intervention to usual care. Prevalence was determined, and risk factors for poly-tobacco use were evaluated using logistic regression. Results: In this cohort of HIV-positive cigarette smokers, 21.6% of participants were PTU, with cigars (73.4%) the most common tobacco product ...

*  Direct to Smoker Outreach in a Health Care Setting - Full Text View -

Tobacco use is the leading preventable cause of death in the United States. Effective treatment for tobacco dependence exists and includes counseling and pharmacotherapy with nicotine replacement, bupropion, or varenicline. The health care system is a key channel for delivering this treatment to smokers. Brief clinical interventions delivered at office visits increase smoking cessation rates, are among the most cost-effective of medical interventions, and are recommended by U.S. Public Health Service. However, physicians and other clinicians often fail to provide them. Clinicians' rates of providing tobacco treatment in ambulatory care can be improved, but even when successful, clinicians can only reach smokers who make an office visit.. A health care system might improve its delivery of tobacco treatment by supplementing visit-based efforts with a population-based strategy, using methods proven effective in public health settings. A population of smokers could be identified ...

*  Tobacco Cessation Success: Smoking Rates Drop for Registered Nurses - RWJF

Health care professionals who smoke often represent a significant obstacle to getting patients to stop smoking. Among registered nurses in particular, smoking limits their ability to be strong advocates for cessation interventions.

*  Freedom-2-Choose (Scotland): Allies retaliate against prohibitionists in the Lancet

The original Lancet letter was written last December by STIVORO, the Dutch tobacco control outfit, and a collection of professional tobacco control activists who are appalled at official Dutch resistance to the collective tobacco control wisdom: Robert West, Stanton Glantz ... see for yourselves. Its chief exhibit of evidence is a diagram that purports to show that the Dutch public is less aware of the dangers of tobacco than the rest of humankind: this diagram is used as the basis of a claim that tobacco control spending should be going up rather than down. The reply, signed by a handful of anti-tobacco control activists on both sides of the Atlantic, points out that nowhere has any significant reduction taken place following smoking bans, and that the proposed cuts in smoking cessation activities by the Dutch health authorities will mostly remain intact. It includes a table showing the smoking figures, complete with sources ...

*  The Rest of the Story: Tobacco News Analysis and Commentary: July 2013

At that time, I wrote: "If this blog were a PolitiFact fact checker, Alere Wellbeing's claim would get a rating of ... FALSE. Or more properly, a rating of: "Liar, Liar, Pants on Fire." It is not clear on what scientific basis Alere Wellbeing makes its claim, but presumably it comes from a study in which its own study team reported about a 41% quit rate for the program. However, this is based on the assumption that every smoker who was not successfully followed up was a quitter. Obviously, this is an unreasonable assumption. In an intent-to-treat analysis (which is the appropriate one to use), the quit rate was only 20.5%. It it were being honest, Alere Wellbeing would advertise a quit rate of 21%, instead of 47%. ... If one cherry picks from the literature, the highest quit rate I can find - based on an intent to treat analysis - is 33% from this study. In more realistic settings, such as this study of the Quit for Life program in actual routine use in Florida, the quit rate was only 16% (and ...

*  Drunk Mice Depressed on Abstinence

It's not just humans who get the blues when they abstain from alcohol, for even mice become depressed and lose brain cells when they stay away from liquor, says a new study.

Tobacco cessation clinicBupropionNicotine replacement therapySIB-1553ACones Hotline: The Cones Hotline was a telephone hotline introduced by the former Prime Minister of the United Kingdom John Major in June 1992 to allow members of the public to enquire about roadworks on the country's roads and report areas where traffic cones had been deployed on a road for no apparent reason. The telephone number for the hotline (originally 0345 504030, later 08457 504030) was usually displayed on signs after sections of roadworks.Gum base: Gum base is the non-nutritive, non-digestible, water-insoluble masticatory delivery system used to carry sweeteners, flavors and any other substances in chewing gum and bubble gum. It provides all the basic textural and masticatory properties of gum.Benzodiazepine withdrawal syndromeBenazeprilBesins HealthcareNBQXTemporal analysis of products: Temporal Analysis of Products (TAP), (TAP-2), (TAP-3) is an experimental technique for studyingLifestyle management programme: A lifestyle management programme (also referred to as a health promotion programme, health behaviour change programme, lifestyle improvement programme or wellness programme) is an intervention designed to promote positive lifestyle and behaviour change and is widely used in the field of health promotion.Herbal smokeless tobaccoClosed-ended question: A closed-ended question is a question format that limits respondents with a list of answer choices from which they must choose to answer the question.Dillman D.Standard evaluation frameworkList of Parliamentary constituencies in Kent: The ceremonial county of Kent,Online patient education: Online Patient Education also known as Online Patient Engagement is a method of providing medical information and education to patients using Learning Management Systems delivered through the Internet.Evaluation of bariatric Centers of Excellence Web sites for functionality and efficacy.Roger Gould: Roger Gould, M.D.Dopamine reuptake inhibitor: A dopamine reuptake inhibitor (DRI) is a type of drug which acts as a reuptake inhibitor of the monoamine neurotransmitter dopamine by blocking the action of the dopamine transporter (DAT). Reuptake inhibition is achieved when extracellular dopamine not absorbed by the postsynaptic neuron is blocked from re-entering the presynaptic neuron.Telephone numbers in Panama: Country Code: +507QRISK: QRISK2 (the most recent version of QRISK) is a prediction algorithm for cardiovascular disease (CVD) that uses traditional risk factors (age, systolic blood pressure, smoking status and ratio of total serum cholesterol to high-density lipoprotein cholesterol) together with body mass index, ethnicity, measures of deprivation, family history, chronic kidney disease, rheumatoid arthritis, atrial fibrillation, diabetes mellitus, and antihypertensive treatment.Smoke-free Environments Act 1990: The Smoke-free Environments Act 1990 is an Act of Parliament in New Zealand.Twelve Traditions: The Twelve Traditions of twelve-step programs provide guidelines for relationships between the twelve-step groups, members, other groups, the global fellowship, and society at large. Questions of finance, public relations, donations, and purpose are addressed in the Traditions.Behavior: Behavior or behaviour (see spelling differences) is the range of actions and [made by individuals, organism]s, [[systems, or artificial entities in conjunction with themselves or their environment, which includes the other systems or organisms around as well as the (inanimate) physical environment. It is the response of the system or organism to various stimuli or inputs, whether [or external], [[conscious or subconscious, overt or covert, and voluntary or involuntary.Bio Base EuropeInternet organizations: This is a list of Internet organizations, or organizations that play or played a key role in the evolution of the Internet by developing recommendations, standards, and technology; deploying infrastructure and services; and addressing other major issues.Behavior change (public health): Behavior change is a central objective in public health interventions,WHO 2002: World Health Report 2002 - Reducing Risks, Promoting Healthy Life Accessed Feb 2015 http://www.who.Utah College of Dental HygienePrenatal nutrition: Nutrition and weight management before and during :pregnancy has a profound effect on the development of infants. This is a rather critical time for healthy fetal development as infants rely heavily on maternal stores and nutrient for optimal growth and health outcome later in life.School health education: School Health Education see also: Health Promotion is the process of transferring health knowledge during a student's school years (K-12). Its uses are in general classified as Public Health Education and School Health Education.Advertising Standards Canada: Advertising Standards Canada (ASC) is the advertising industry's non-profit self-regulating body created in 1957 to ensure the integrity and viability of advertising in Canada. The organization includes over 160 advertisers, advertising agencies, media organizations, and suppliers to the advertising sector.Breath carbon monoxide: Breath carbon monoxide is the level of carbon monoxide in a person's exhalation. It can be measured in a breath carbon monoxide test, generally by using a carbon monoxide breath monitor (breath CO monitor), such as for motivation and education for smoking cessation and also as a clinical aid in assessing carbon monoxide poisoning.Smokefree Environments Amendment Act 2003: The Smokefree Environments Amendment Bill was passed by the Parliament of New Zealand on 3 December 2003. The smoking ban legislation calls for progressive introduction of various clauses to totally ban smoking in all workplaces including offices, clubs, pubs, restaurants, airports, schools etc.Join My Cult: Join My Cult is a subversive, satirical novel written by James Curcio and released by New Falcon Publications (publisher of some notable counter-culture authors such Robert Anton Wilson, Timothy Leary, and Aleister Crowley). It is a work of collaborative fiction based on real events.Placebo-controlled study: Placebo-controlled studies are a way of testing a medical therapy in which, in addition to a group of subjects that receives the treatment to be evaluated, a separate control group receives a sham "placebo" treatment which is specifically designed to have no real effect. Placebos are most commonly used in blinded trials, where subjects do not know whether they are receiving real or placebo treatment.Telegraphy: Telegraphy (from Greek: τῆλε ["at a distance" and γράφειν gráphein], "to write") is the long-distance transmission of textual or symbolic (as opposed to verbal or audio) messages without the physical exchange of an object bearing the message. Thus [[flag semaphore|semaphore is a method of telegraphy, whereas pigeon post is not.Incremental cost-effectiveness ratio: The incremental cost-effectiveness ratio (ICER) is a statistic used in cost-effectiveness analysis to summarise the cost-effectiveness of a health care intervention. It is defined by the difference in cost between two possible interventions, divided by the difference in their effect.California Proposition 29 (2012): Proposition 29, the California Cancer Research Act, is a California ballot measure that was defeated by California voters at the statewide election on June 5, 2012.Duragesic: Duragesic and Durogesic are trade names of fentanyl transdermal patches, used for relief of moderate to severe pain. The patches release fentanyl, a potent opioid, slowly through the skin.Exercise addiction: An exercise addiction can have harmful consequences although it is not listed as a disorder in the latest revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). This type of addiction can be classified under a behavioral addiction in which a person’s behavior becomes obsessive, compulsive, and/or causes dysfunction in a person's life.Konop v. Hawaiian Airlines, Inc.: Konop v. Hawaiian Airlines, Inc.Psychiatric interview: The psychiatric interview refers to the set of tools that a mental health worker (most times a psychiatrist or a psychologist but at times social workers or nurses) uses to complete a psychiatric assessment.United States Public Health ServiceSocial marketing: Social marketing seeks to develop and integrate marketing concepts with other approaches to influence behaviors that benefit individuals and communities for the greater social good. It seeks to integrate research, best practice, theory, audience and partnership insight, to inform the delivery of competition sensitive and segmented social change programs that are effective, efficient, equitable and sustainable.AIP Conference Proceedings: AIP Conference Proceedings is a serial published by the American Institute of Physics since 1970. It publishes the proceedings from various conferences of physics societies.Mass media impact on spatial perception: Mass media influences spatial perception through journalistic cartography and spatial bias in news coverage.Limiting reagent: The limiting reagent (or limiting reactant) in a chemical reaction is the substance which is totally consumed when the chemical reaction is complete. The amount of product formed is limited by this reagent since the reaction cannot proceed further without it.Age adjustment: In epidemiology and demography, age adjustment, also called age standardization, is a technique used to allow populations to be compared when the age profiles of the populations are quite different.

(1/4169) Body mass decrease after initial gain following smoking cessation.

BACKGROUND: Although smoking cessation is strongly associated with subsequent weight gain, it is not clear whether the initial gain in weight after smoking cessation remains over time. METHOD: Cross-sectional analyses were made, using data from periodic health examinations for workers, on the relationship between body mass index (BMI) and the length of smoking cessation. In addition, linear regression coefficients of BMI on the length of cessation were estimated according to alcohol intake and sport activity, to examine the modifying effect of these factors on the weight of former smokers. RESULTS: Means of BMI were 23.1 kg/m2, 23.3 kg/m2, 23.6 kg/m2 for light/medium smokers, heavy smokers and never smokers, respectively. Among former smokers who had smoked > or = 25 cigarettes a day, odds ratio (OR) of BMI >25 kg/m2 were 1.88 (95% confidence interval [CI] : 1.05-3.35), 1.32 (95% CI : 0.74-2.34), 0.66 (95% CI: 0.33-1.31) for those with 2-4 years, 5-7 years, and 8-10 years of smoking cessation, respectively. The corresponding OR among those who previously consumed <25 cigarettes a day were 1.06 (95% CI: 0.58-1.94), 1.00 (95% CI: 0.58-1.71), and 1.49 (95% CI: 0.95-2.32). CONCLUSIONS: The results suggest that although heavy smokers may experience large weight gain and weigh more than never smokers in the few years after smoking cessation, they thereafter lose weight to the never smoker level, while light and moderate smokers gain weight up to the never smoker level without any excess after smoking cessation.  (+info)

(2/4169) A single-blind, placebo-controlled trial of a simple acupuncture treatment in the cessation of smoking.

BACKGROUND: Tobacco smoking is a major cause of preventable disease and premature death. Physicians should play an active role in the control of smoking by encouraging cessation and helping the smoker to choose the most suitable aid to cessation. AIM: To evaluate a simple, ear acupuncture treatment for the cessation of smoking. METHOD: Randomized, single-blind, placebo-controlled trial of 78 currently smoking volunteers from the general public. Volunteers attended an acupuncture clinic in a general practice setting and were given a single treatment of electroacupuncture using two needles at either an active or a placebo site plus self-retained ear seeds for two weeks. The major outcome measure was biochemically validated total cessation of smoking at six months. RESULTS: A total of 12.5% of the active treatment group compared with 0% of the placebo group ceased smoking at six months (P = 0.055, 95% confidence interval -0.033 to 0.323). CONCLUSION: This simple ear electroacupuncture treatment was significantly more effective in helping volunteers to quit smoking than placebo treatment.  (+info)

(3/4169) A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

BACKGROUND AND METHODS: Use of nicotine-replacement therapies and the antidepressant bupropion helps people stop smoking. We conducted a double-blind, placebo-controlled comparison of sustained-release bupropion (244 subjects), a nicotine patch (244 subjects), bupropion and a nicotine patch (245 subjects), and placebo (160 subjects) for smoking cessation. Smokers with clinical depression were excluded. Treatment consisted of nine weeks of bupropion (150 mg a day for the first three days, and then 150 mg twice daily) or placebo, as well as eight weeks of nicotine-patch therapy (21 mg per day during weeks 2 through 7, 14 mg per day during week 8, and 7 mg per day during week 9) or placebo. The target day for quitting smoking was usually day 8. RESULTS: The abstinence rates at 12 months were 15.6 percent in the placebo group, as compared with 16.4 percent in the nicotine-patch group, 30.3 percent in the bupropion group (P<0.001), and 35.5 percent in the group given bupropion and the nicotine patch (P<0.001). By week 7, subjects in the placebo group had gained an average of 2.1 kg, as compared with a gain of 1.6 kg in the nicotine-patch group, a gain of 1.7 kg in the bupropion group, and a gain of 1.1 kg in the combined-treatment group (P<0.05). Weight gain at seven weeks was significantly less in the combined-treatment group than in the bupropion group and the placebo group (P<0.05 for both comparisons). A total of 311 subjects (34.8 percent) discontinued one or both medications. Seventy-nine subjects stopped treatment because of adverse events: 6 in the placebo group (3.8 percent), 16 in the nicotine-patch group (6.6 percent), 29 in the bupropion group (11.9 percent), and 28 in the combined-treatment group (11.4 percent). The most common adverse events were insomnia and headache. CONCLUSIONS: Treatment with sustained-release bupropion alone or in combination with a nicotine patch resulted in significantly higher long-term rates of smoking cessation than use of either the nicotine patch alone or placebo. Abstinence rates were higher with combination therapy than with bupropion alone, but the difference was not statistically significant.  (+info)

(4/4169) Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society.

The Collaborative European Anti-Smoking Evaluation (CEASE) was a European multicentre, randomized, double-blind placebo controlled smoking cessation study. The objectives were to determine whether higher dosage and longer duration of nicotine patch therapy would increase the success rate. Thirty-six chest clinics enrolled a total of 3,575 smokers. Subjects were allocated to one of five treatment arms: placebo and either standard or higher dose nicotine patches (15 mg and 25 mg daily) each given for 8 or 22 weeks with adjunctive moderately intensive support. The 12 month sustained success rates were: 25 mg patch for 22 weeks (L-25), 15.4%; 25 mg patch for 8 weeks (S-25), 15.9%; 15 mg patch for 22 weeks (L-15), 13.7%; 15 mg patch for 8 weeks (S-15), 11.7%; and placebo (P-0) 9.9% (placebo versus 15 mg, p<0.05; 25 mg versus 15 mg, p<0.03; 25 mg versus placebo, p<0.001, Chi-squared test). There was no significant difference in success rate between the two active treatment durations. Of the first week abstainers (n=1,698), 25.1% achieved success at 12 months as opposed to first week smokers, 2.7% of 1,877 subjects (p< 0.001). In summary, a higher than standard dose of nicotine patch was associated with an increase in the long-term success in smoking cessation but continuation of treatment beyond 8-12 weeks did not increase the success rates.  (+info)

(5/4169) Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group.

OBJECTIVE: To assess the effectiveness of a programme to coordinate and support follow up care in general practice after a hospital diagnosis of myocardial infarction or angina. DESIGN: Randomised controlled trial; stratified random allocation of practices to intervention and control groups. SETTING: All 67 practices in Southampton and south west Hampshire, England. SUBJECTS: 597 adult patients (422 with myocardial infarction and 175 with a new diagnosis of angina) who were recruited during hospital admission or attendance at a chest pain clinic between April 1995 and September 1996. INTERVENTION: Programme to coordinate preventive care led by specialist liaison nurses which sought to improve communication between hospital and general practice and to encourage general practice nurses to provide structured follow up. MAIN OUTCOME MEASURES: Serum total cholesterol concentration, blood pressure, distance walked in 6 minutes, confirmed smoking cessation, and body mass index measured at 1 year follow up. RESULTS: Of 559 surviving patients at 1 year, 502 (90%) were followed up. There was no significant difference between the intervention and control groups in smoking (cotinine validated quit rate 19% v 20%), lipid concentrations (serum total cholesterol 5.80 v 5.93 mmol/l), blood pressure (diastolic pressure 84 v 85 mm Hg), or fitness (distance walked in 6 minutes 443 v 433 m). Body mass index was slightly lower in the intervention group (27.4 v 28.2; P=0.08). CONCLUSIONS: Although the programme was effective in promoting follow up in general practice, it did not improve health outcome. Simply coordinating and supporting existing NHS care is insufficient. Ischaemic heart disease is a chronic condition which requires the same systematic approach to secondary prevention applied in other chronic conditions such as diabetes mellitus.  (+info)

(6/4169) The reach and effectiveness of a national mass media-led smoking cessation campaign in The Netherlands.

OBJECTIVES: This study examined the reach, effectiveness, and cost-effectiveness of a mass media-led smoking cessation campaign including television shows, a television clinic, a quit line, local group programs, and a comprehensive publicity campaign. METHODS: A random sample of baseline smokers (n = 1338) was interviewed before and after the campaign and at a 10-month follow-up. A nonpretested control group (n = 508) of baseline smokers was incorporated to control for test effects. RESULTS: Most smokers were aware of the campaign, although active participation rates were low. Dose-response relations between exposure and quitting were found. The follow-up point prevalence abstinence rate attributable to the campaign was estimated to be 4.5% after control for test effects and secular trends. The cost per long-term quitter was about $12. CONCLUSIONS: In spite of a massive rise in tobacco promotion expenditures prior to the campaign and the absence of governmental control over the media, the campaign under study may have increased normal cessation rates substantially.  (+info)

(7/4169) Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994.

OBJECTIVE: To estimate the fall in coronary heart disease (CHD) mortality in Scotland attributable to medical and surgical treatments, and risk factor changes, between 1975 and 1994. DESIGN: A cohort model combining effectiveness data from meta-analyses with information on treatment uptake in all patient categories in Scotland. SETTING AND PATIENTS: The whole Scottish population of 5.1 million, including all patients with recognised CHD. INTERVENTIONS: All cardiological, medical, and surgical treatments, and all risk factor changes between 1975 and 1994. Data were obtained from epidemiological surveys, routine National Health Service sources, and local audits. MAIN OUTCOME MEASURES: Deaths from CHD in 1975 and 1994. RESULTS: There were 15 234 deaths from CHD in 1994, 6205 fewer deaths than expected if there had been no decline from 1975 mortality rates. In 1994, the total number of deaths prevented or postponed by all treatments and risk factor reductions was estimated at 6747 (minimum 4790, maximum 10 695). Forty per cent of this benefit was attributed to treatments (initial treatments for acute myocardial infarction 10%, treatments for hypertension 9%, for secondary prevention 8%, for heart failure 8%, aspirin for angina 2%, coronary artery bypass grafting surgery 2%, and angioplasty 0.1%). Fifty one per cent of the reduction in deaths was attributed to measurable risk factor reductions (smoking 36%, cholesterol 6%, secular fall in blood pressure 6%, and changes in deprivation 3%). Other, unquantified factors apparently accounted for the remaining 9%. These proportions remained relatively consistent across a wide range of assumptions and estimates in a sensitivity analysis. CONCLUSIONS: Medical treatments and risk factor changes apparently prevented or postponed about 6750 coronary deaths in Scotland in 1994. Modest gains from individual treatments produced a large cumulative survival benefit. Reductions in major risk factors explained about half the fall in coronary mortality, emphasising the importance and future potential of prevention strategies.  (+info)

(8/4169) Influence of physician and patient gender on provision of smoking cessation advice in general practice.

OBJECTIVE: To examine the association between physician and patient gender and physicians' self-reported likelihood of providing smoking cessation advice to smokers using hypothetical case scenarios in primary care. DESIGN: Cross-sectional analysis of a self-administered questionnaire. SUBJECTS: National random sample of Australian general practitioners (GPs). MAIN OUTCOME MEASURES: Self-reported likelihood of advising hypothetical male and female smokers to stop smoking during a consultation for ear-syringing ("opportunistic" approach) or a dedicated preventive health "check up". RESULTS: 855 GPs returned questionnaires (67% response rate). Significantly more respondents indicated they would be "highly likely" to initiate an opportunistic discussion about smoking with a male smoker (47.8% (95% confidence intervals (CI) = 44.5 to 51.2)) than a female smoker (36.3% (95% CI = 33.1 to 39.5]). Older, male GPs were less likely to adopt an opportunistic approach to smoking cessation for patients of either sex. Respondents were more likely to recommend that a male patient return for a specific preventive health check up. Furthermore, in the context of a health check up, a greater proportion in total of respondents indicated they would be "highly likely" to discuss smoking with a man (86.9%, 95% CI = 84.5 to 89.0) than a female smoker (82.5%, 95% CI = 79.8 to 84.9). CONCLUSIONS: As measured by physician self-report, the likelihood of advising smokers to quit during primary care consultations in Australia appears to be influenced by gender bias. Gender-sensitive strategies to support cessation activities are recommended.  (+info)


  • Only approved cessation drugs (varenicline, bupropion, and nicotine replacement therapy) were considered. (
  • It is possible to offer smoking cessation treatment including varenicline to patients scheduled for elective surgery. (
  • The smoking cessation interventions include counseling, nicotine replacement therapy, buproprion therapy, and varenicline therapy. (


  • Pregnant smokers (n=270) who smoke at least 5 cigarettes/ day will receive nurse-delivered behavioral counseling and be randomized to receive a 6-week course of treatment with either a nicotine inhaler or placebo, followed by a 6-week taper. (
  • RATIONALE: Contingency management is a behavioral treatment approach that provides immediate rewards for positive change in behavior such as quitting smoking. (
  • Compare the relative efficacy of ten weeks of once weekly 250 mg D-cycloserine (DCS) vs. placebo (both in conjunction with cognitive behavioral therapy (CBT) and nicotine replacement therapy (NRT) on reducing cigarette smoking in treatment-seeking nicotine-dependent outpatients. (


  • Bupropion is an antidepressant, but it is also prescribed to help people quit smoking . (
  • Start taking bupropion 1-2 weeks before you plan to stop smoking. (
  • Most people do not have side effects from taking bupropion for smoking cessation. (
  • A smoking cessation (stop-smoking) program that combines contingency management with bupropion and counseling may be effective in helping cancer survivors stop smoking. (
  • PURPOSE: Randomized clinical trial to compare the effectiveness of bupropion and counseling with or without contingency management in helping cancer survivors stop smoking. (
  • Compare the feasibility of a multi-component smoking cessation intervention comprising bupropion and counseling with or without contingency management (cash reward) for cancer survivors who continue to smoke. (


  • This is a randomized, prospective trial that will evaluate a cellular phone delivered counseling intervention versus standard of care for smoking cessation. (
  • In addition, except pharmacological intervention, readiness to change may be an important factor affecting the outcomes of smoking reduction. (
  • Yet these results are largely found in many non-pharmacological intervention and smoking cessation programs for general population. (
  • 1. The Pharmacogenetic Study of Interaction Among Antipsychotics, Readiness to Change, and Pharmacological Intervention for Smoking Cessation Among Schizophrenic Patients 2. (
  • Patients are randomized to 1 of 2 smoking cessation intervention arms. (
  • An approach for developing and evaluating an intervention for smoking cessation is presented along with a measurement tool. (


  • Thus, we have an a great interest in examining the association between the stages of change and the outcomes of smoking- cessation along with reduction among schizophrenic patients receiving transdermal nicotine patches. (
  • Primary outcomes will include smoking as measured by carbon monoxide levels and self-report measurements. (
  • We also identify differences in maternal behaviors and birth outcomes between women who did and did not quit smoking during pregnancy, among women who smoked before pregnancy. (


  • Compare 7-day point-prevalence abstinence rates in patients treated with these smoking cessation interventions. (
  • Patients are followed at 12 and 24 weeks after the completion of the smoking cessation interventions. (
  • Moreover, there is a need for a robust theory that can guide smoking cessation counseling interventions and increase the success rates. (


  • The aim of the study was to assess the budgetary impact of funding smoking-cessation drugs in COPD patients in Spain. (
  • The pharmaceutical costs for smoking-cessation drugs, extra medical follow-up as a consequence of public reimbursement, and annual savings for health costs avoided due to stopping smoking were considered. (
  • Funding smoking-cessation drugs in COPD patients seems to be an efficient option and a National Health System drug reimbursement scheme would represent a cost-saving policy in Spain. (


  • To examine the efficacy of the nicotine inhaler compared to a matched placebo for smoking cessation and reduction among pregnant smokers. (
  • Programs for quitting smoking have played a significant role in reduction of smoking in the United States. (


  • Conclusions: While many women who smoke before becoming pregnant reduce the amount of cigarettes smoked during pregnancy, these women are having a difficult time completely quitting. (


  • Irrespective of the drug, the model allowed for an initial cessation attempt, and up to three additional attempts in case of failure or smoking relapse during a 5-year period. (


  • Cigarette smoke affects bonding to dentin. (
  • Traditional risk factors for coronary artery disease, including cigarette smoking, likely play a large role. (
  • Cigarette smoking represents a major health problem for patients suffering from schizophrenia. (
  • They also are more likely to be heavy smokers, and tend to be exposed disproportionately to nicotine and other harmful ingredients in the cigarette because of the observed tendency to smoke down to the very end. (
  • Change from baseline in cigarette smoking at 10 weeks as measured by carbon monoxide levels and self-report measurements. (
  • Tobacco use and cigarette smoking are a major preventable public health problem globally. (
  • 1 In the United States from 1965 to 2010, the prevalence of cigarette smoking among adults has decreased from 42.4% to 17.8% but is still a major public health issue. (
  • Mothers who smoked before pregnancy and smoked at least one cigarette a day during the last three months of pregnancy are defined as persistent smokers, and those who smoked before pregnancy and did not smoke at least one cigarette a day during the last three months of pregnancy are defined as quitters in this study. (
  • Results: Overall, 24.6 percent of women reported cigarette smoking before pregnancy, 13.8 percent during pregnancy, and 20.3 percent after pregnancy. (


  • Smoking is a prevalent behavior with severe health consequences. (
  • Till now, no available study solely focus readiness of change quitting smoking behavior in NRT treatment for chronic schizophrenic patients. (
  • A fourth generation approach using multi-theory model (MTM) of health behavior change is introduced in this article for smoking cessation. (
  • A literature review reifying the MTM of health behavior change for smoking cessation has been presented. (
  • An instrument designed to measure constructs of MTM and associated smoking cessation behavior has been developed. (


  • Various smoking cessation methods that are available to dentists include nicotine replacement therapies, other pharmacological agents, and biobehavioral therapies. (
  • Currently, there is little information available regarding the efficacy and utility of smoking cessation treatment methods, as well as factors that may predict patients' response to such treatments. (


  • There's good news for smokers who'd like the benefit of the St. Helena Center for Health's Smoke-Free Life® program ( ) without committing to a week of residential treatment. (
  • Thousands of smokers from all over the world have quit for good through our inpatient program,' said Sue Raring, smoking-cessation nurse specialist. (
  • Quitting smoking is advantageous for health especially for smokers who quit before the age of 35 years as their mortality rates are similar to those who have never smoked. (
  • In 2010, the Centers for Disease Control and Prevention (CDC) reported that 68.8% of adult smokers wanted to stop smoking and 52.4% had made a quit attempt in the past year but only 6.2% had been successful in quitting. (


  • An important related issue is the influence of smoking , and its cessation, on the effects of the medications most of these patients rely upon for the control of their psychiatric symptoms. (


  • Nicotine replacement products are used to help people stop smoking . (
  • Smoking and using nicotine replacement products can be dangerous because nicotine can build up to toxic levels. (
  • Since your goal is to quit smoking entirely, you should not smoke while using a nicotine replacement product. (
  • After quitting smoking, the goal is to end your use of the nicotine replacement products as well. (
  • Some should not be taken when you are quitting smoking with nicotine replacement products, while others may require a different dosage level. (


  • A stop-smoking program costs much less than treating the health problems of a long-time smoker,' said Raring. (
  • Smoking continues to be a public health problem worldwide. (
  • According to the World Health Organization (WHO) in 2012, 21% of the total world population above 15 years smoked tobacco. (
  • Reducing the percentage of women who smoke during pregnancy is a National Healthy People 2010 objective and should remain a priority of North Carolina public health programs. (

quit smoking d

  • Mothers who did not quit smoking during pregnancy were significantly more likely to deliver a low birth weight baby and to have their infant exposed to second- hand smoke after giving birth and less likely to breastfeed. (


  • This project will examine the safety and efficacy of the nicotine inhaler as an aid to smoking cessation during pregnancy. (


  • Determine the characteristics of these patients that predict success at quitting smoking. (
  • No. 138 October 2003 Tobacco Use Among Pregnant Women in North Carolina: Predictors of Smoking Cessation During Pregnancy Results from the North Carolina Pregnancy Risk Assessment Monitoring System ( PRAMS), 1997- 2001 by Matt Avery, M. A. Willona Stallings, B. A. ABSTRACT Objectives: This study examines the differences in the rate of smoking cessation during pregnancy among mothers who smoked before pregnancy, by selected maternal characteristics. (
  • After controlling for demographic and other characteristics, the strong predictors of smoking cessation during pregnancy were low intensity of smoking before pregnancy, higher maternal education, higher income, and no previous births. (


  • The prevalence of smoking in the HIV patient population is higher than the general population. (

pregnant women

  • This is a clinical trial to determine if the nicotine inhaler in combination with counseling will help pregnant women quit smoking, and whether it is safe when compared to placebo (an inactive inhaler). (
  • Tobacco use among pregnant women in North Carolina : predictors of smoking cessation during. (


  • The model estimated that 17,756 COPD patients would stop smoking if public funding was available, compared with 1,303 without reimbursement. (
  • Less than four percent of women who smoked before their pregnancy reported receiving classes on how to stop smoking during their pregnancy. (
  • AS3 is open to anyone who has a desire to stop smoking. (


  • To identify factors that determine which women benefit most from the use of nicotine inhaler for smoking cessation during pregnancy. (
  • For most analyses in this study, we exclude women who did not smoke before pregnancy ( 5,608) and those with data missing on smoking before or during pregnancy ( 255). (
  • Of those who smoked before pregnancy and quit during pregnancy, roughly half began smoking again by the time they completed the PRAMS survey at 3- 6 months postpartum. (
  • More work is needed to educate women on the dangers of smoking during their pregnancy, particularly those in high- risk groups. (


  • The outpatient program offers a complete evaluation by John Hodgkin, MD, the medical director of the Smoke-Free Life® program, and James Peters, MD, preventive medicine specialist. (
  • Creation of the outpatient Smoke-Free Life® program is supported by a gift of $500,000 from the family of Marjorie Mondavi in her honor. (
  • Free, expert led, group smoking cessation program. (
  • A free online smoking cessation program with quit smoking resources. (


  • In our sub-study, we will evaluate rates of progression in atherosclerosis in HIV/AIDS patients who quit smoking versus those who continue smoking by measuring carotid intima-media thickness(CIMT) and biomarkers of atherosclerosis at time point baseline, 1 year, and 3 year. (
  • The primary endpoint will compare change in mean maximum carotid IMT over the course of the study between HIV patients who quit smoking and those that continue to smoke. (
  • 50 HIV infected patients who enroll in a parent protocol to quit smoking and elect to participate in this sub-study. (
  • The goal of this sub-study is to assess the effect of a modifiable coronary artery disease risk factor, smoking, in HIV/AIDS patients through this collaboration of cardiovascular expertise and metrics. (
  • This study will evaluate whether or not this will enable some patients to quit smoking for up to 4 weeks prior to surgery and in turn, whether this may lead to reductions in post-operative complication such as wound infections. (
  • The instrument developed is available for validation, reliability and prediction study pertaining to smoking cessation. (


  • Further, smoking in these patients may be associated with a higher risk for developing tardive dyskinesia All of these factors render schizophrenic patients a particularly vulnerable group for the detrimental effects of tobacco-related medical problems. (
  • Although smoking has long been known to significantly alter the metabolism, and thus the effects, of most antipsychotics, the extent and clinical significance of these influences have rarely been assessed. (
  • The typical effects of withdrawal are reduced as your body adjusts to not smoking. (
  • Smoking and tobacco use are associated with a number of negative effects. (


  • The Smoke-Free Life® team provides a medically monitored, personalized treatment approach that uses the latest smoking-cessation research. (
  • Arm II: Patients receive treatment as in arm I and contingency management (i.e., monetary reinforcement for not smoking) on weeks 1-6. (


  • Also, your doctor can prescribe additional smoking cessation aids and can refer you to a counselor, support group , or other services that may help you quit smoking. (


  • Smoking cessation in the dental setting: a practical approach. (


  • This article presents a smoking cessation protocol that can be carried out as part of routine oral care. (


  • The central hypothesis is that smoking cessation win slow the atherosclerosis progression in HIV patients. (


  • Smoking and tobacco use are associated with cardiovascular diseases that include coronary heart disease, atherosclerosis, cerebrovascular disease, and abdominal aortic aneurysm. (


  • If you still have the urge to smoke, you may need an additional strategy to quit. (


  • If you are pregnant, planning on becoming pregnant, or breastfeeding, talk to your doctor to select a safe method to quit smoking. (


  • It is very clear from all of the studies on smoking cessation that your chance of long-term success depends a great deal on your motivation and commitment to quitting, regardless of which therapy you choose. (


  • We will also evaluate rates of progression of CIMT in those who quit smoking versus those who continue smoking, based on race, sex, state of HIV disease, comorbid diseases, and lipid profile. (


  • Sometimes these products are used in combination, like the patch along with the lozenges, which may help some people stay smoke-free. (


  • Sites in this category serve the support needs of people who currently smoke and wish to quit. (
  • Bulletin board for people who have, or would like to, successfully quit smoking. (